Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals
(AUPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Lupkynis
Voclosporin
2021-01-22
2023-2037
Lupus nephritis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Voclosporin
drug interactions
,
eye diseases
,
kidney diseases
,
focal segmental glomerulosclerosis
,
covid-19
,
lupus nephritis
,
nephritis
,
psoriasis
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
kidney transplantation
,
keratoconjunctivitis
,
syndrome
,
chronic disease
Mycophenolate sodium
immunosuppression therapy
,
healthy volunteers/patients
,
microscopic polyangiitis
,
congenital abnormalities
,
chronic kidney failure
,
systemic scleroderma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
hypoglycemia
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
hypertension
,
iga glomerulonephritis
,
renal hypertension
,
diabetes mellitus
,
bullous pemphigoid
,
psoriasis
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
type 1 diabetes mellitus
,
neuromyelitis optica
,
pemphigus
,
myasthenia gravis
,
diabetic nephropathies
,
multiple sclerosis
,
cardiovascular diseases
,
lung transplantation
,
sarcoidosis
,
pulmonary sarcoidosis
,
membranous glomerulonephritis
,
kidney transplantation
,
liver transplantation
,
heart transplantation
,
kidney diseases
,
renal insufficiency
,
polyomavirus infections
,
corneal transplantation
,
liver diseases
,
hiv infections
,
graft vs host disease
,
hematopoietic stem cell transplantation
Bevifimod
healthy volunteers/patients
,
renal insufficiency
,
hepatic insufficiency
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
t-cell lymphoma
,
hodgkin disease
,
follicular lymphoma
,
b-cell lymphoma
,
t-cell lymphoma cutaneous
,
bronchiolitis obliterans syndrome
,
glomerulonephritis
,
membranoproliferative glomerulonephritis
,
hemolytic anemia autoimmune
,
iga glomerulonephritis
,
lupus nephritis
,
amyloidosis
,
myasthenia gravis
,
immunoglobulin light-chain amyloidosis
,
paraproteinemias
,
hypophosphatasia
,
paroxysmal hemoglobinuria
Nepidermin
postmenopausal osteoporosis
,
macular degeneration
,
wet macular degeneration
,
paroxysmal hemoglobinuria
,
hemoglobinuria
,
psoriasis
,
non-small-cell lung carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use